Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'Responses Against Paramyxoviruses in T cells with crOss Reactivity'. The following are the other r... और पढ़ें
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'Effect of innate immune reprogramming by primary dengue on host response to secondary dengue'. The... और पढ़ें
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'Validation of Gore Test in patients with Sphincteric Dyssynergia presenting with Dysfunctional Voi... और पढ़ें
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'An open-label, randomized, controlled phase 3 study of enfortumab vedotin in combination with pemb... और पढ़ें
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and... और पढ़ें
U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07894913) titled 'Oral Bromelain After Bilateral Mandibular Third Molar Surgery' on Oct. 19. Brief Summary: ... और पढ़ें
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled, 3-Arm Study to Investigate the Safety and... और पढ़ें
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A double-blind, randomised, placebo-controlled trial evaluating the efficacy and safety of oral ne... और पढ़ें
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Investigator and Participant Blinded, Single Ascending ... और पढ़ें
Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Double-Blind, Active-Control, Multicenter Phase 3 Trial of Casdatifan and Cabozantin... और पढ़ें